chrX-74740352-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001008537.3(NEXMIF):āc.4205A>Gā(p.Asn1402Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,210,165 control chromosomes in the GnomAD database, including 1 homozygotes. There are 36 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001008537.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEXMIF | NM_001008537.3 | c.4205A>G | p.Asn1402Ser | missense_variant | 3/4 | ENST00000055682.12 | NP_001008537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEXMIF | ENST00000055682.12 | c.4205A>G | p.Asn1402Ser | missense_variant | 3/4 | 1 | NM_001008537.3 | ENSP00000055682.5 | ||
NEXMIF | ENST00000616200.2 | c.4205A>G | p.Asn1402Ser | missense_variant | 3/5 | 1 | ENSP00000480284.1 | |||
NEXMIF | ENST00000642681.2 | c.4205A>G | p.Asn1402Ser | missense_variant | 3/3 | ENSP00000495800.1 |
Frequencies
GnomAD3 genomes AF: 0.000536 AC: 60AN: 111929Hom.: 0 Cov.: 22 AF XY: 0.000704 AC XY: 24AN XY: 34103
GnomAD3 exomes AF: 0.000142 AC: 26AN: 183199Hom.: 1 AF XY: 0.0000738 AC XY: 5AN XY: 67711
GnomAD4 exome AF: 0.0000565 AC: 62AN: 1098183Hom.: 1 Cov.: 32 AF XY: 0.0000330 AC XY: 12AN XY: 363559
GnomAD4 genome AF: 0.000536 AC: 60AN: 111982Hom.: 0 Cov.: 22 AF XY: 0.000702 AC XY: 24AN XY: 34166
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 11, 2020 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
NEXMIF-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at